Macy's, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Macy's, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $22.62B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $23.01B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $23.87B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $25.45B | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | $25.40B | Mar 22, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $21.76B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $22.29B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $23.09B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $24.44B | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | $24.46B | Mar 22, 2024 |
| FY2020 | Jan 30, 2021 | $6.78B | Mar 29, 2021 |
| FY2020 | Oct 31, 2020 | $3.99B | Mar 29, 2021 |
| FY2020 | Aug 1, 2020 | $3.56B | Mar 29, 2021 |
| FY2020 | May 2, 2020 | $3.02B | Mar 29, 2021 |
| FY2020 | Feb 1, 2020 | $8.34B | Mar 29, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Feb 3, 2018 | $8.67B | Apr 4, 2018 |
| FY2017 | Oct 28, 2017 | $5.28B | Apr 4, 2018 |
| FY2017 | Jul 29, 2017 | $5.55B | Apr 4, 2018 |
| FY2017 | Apr 29, 2017 | $5.34B | Apr 4, 2018 |
| FY2017 | Jan 28, 2017 | $8.52B | Apr 4, 2018 |
| FY2017 | Oct 29, 2016 | $5.63B | Apr 4, 2018 |
| FY2017 | Jul 30, 2016 | $5.87B | Apr 4, 2018 |
| FY2017 | Apr 30, 2016 | $5.77B | Apr 4, 2018 |
| FY2016 | Jan 30, 2016 | $8.87B | Mar 29, 2017 |
| FY2016 | Oct 31, 2015 | $5.87B | Mar 29, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Feb 3, 2018 | $3.31B | Apr 4, 2018 |
| FY2017 | Oct 28, 2017 | $2.11B | Apr 4, 2018 |
| FY2017 | Jul 29, 2017 | $2.24B | Apr 4, 2018 |
| FY2017 | Apr 29, 2017 | $2.03B | Apr 4, 2018 |
| FY2017 | Jan 28, 2017 | $3.26B | Apr 4, 2018 |
| FY2017 | Oct 29, 2016 | $2.24B | Apr 4, 2018 |
| FY2017 | Jul 30, 2016 | $2.40B | Apr 4, 2018 |
| FY2017 | Apr 30, 2016 | $2.26B | Apr 4, 2018 |
| FY2016 | Jan 30, 2016 | $3.32B | Mar 29, 2017 |
| FY2016 | Oct 31, 2015 | $2.34B | Mar 29, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $642.00M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $582.00M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $45.00M | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $1.15B | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | $1.43B | Mar 22, 2024 |
| FY2020 | Jan 30, 2021 | $160.00M | Mar 29, 2021 |
| FY2020 | Oct 31, 2020 | ($91.00M) | Mar 29, 2021 |
| FY2020 | Aug 1, 2020 | ($431.00M) | Mar 29, 2021 |
| FY2020 | May 2, 2020 | ($3.58B) | Mar 29, 2021 |
| FY2020 | Feb 1, 2020 | $340.00M | Mar 29, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.03B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $909.00M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $301.00M | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $1.69B | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | $2.35B | Mar 22, 2024 |
| FY2022 | Jan 30, 2021 | ($4.48B) | Mar 24, 2023 |
| FY2021 | Feb 1, 2020 | $970.00M | Mar 25, 2022 |
| FY2020 | Feb 2, 2019 | $1.74B | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $1.86B | Mar 30, 2020 |
| FY2018 | Jan 28, 2017 | $1.37B | Apr 3, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $8.24B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $8.33B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $8.38B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $8.46B | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | $8.15B | Mar 22, 2024 |
| FY2020 | Jan 30, 2021 | $2.05B | Mar 29, 2021 |
| FY2020 | Oct 31, 2020 | $1.73B | Mar 29, 2021 |
| FY2020 | Aug 1, 2020 | $1.40B | Mar 29, 2021 |
| FY2020 | May 2, 2020 | $1.60B | Mar 29, 2021 |
| FY2020 | Feb 1, 2020 | $2.51B | Mar 29, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.43B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $1.28B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $1.31B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $1.62B | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | $2.71B | Mar 22, 2024 |
| FY2022 | Jan 30, 2021 | $649.00M | Mar 24, 2023 |
| FY2021 | Feb 1, 2020 | $1.61B | Mar 25, 2022 |
| FY2020 | Feb 2, 2019 | $1.74B | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $1.98B | Mar 30, 2020 |
| FY2018 | Jan 28, 2017 | $1.80B | Apr 3, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $373.00M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $518.00M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $631.00M | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $888.00M | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | $354.00M | Mar 22, 2024 |
| FY2022 | Jan 30, 2021 | $338.00M | Mar 24, 2023 |
| FY2021 | Feb 1, 2020 | $902.00M | Mar 25, 2022 |
| FY2020 | Feb 2, 2019 | $657.00M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $487.00M | Mar 30, 2020 |
| FY2018 | Jan 28, 2017 | $596.00M | Apr 3, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $16.24B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $16.40B | Mar 27, 2026 |
| FY2024 | Feb 3, 2024 | $16.25B | Mar 21, 2025 |
| FY2023 | Jan 28, 2023 | $16.87B | Mar 22, 2024 |
| FY2022 | Jan 29, 2022 | $17.59B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $17.71B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $21.17B | Mar 29, 2021 |
| FY2019 | Feb 2, 2019 | $19.19B | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $19.58B | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | $19.85B | Apr 4, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $4.86B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $4.55B | Mar 27, 2026 |
| FY2024 | Feb 3, 2024 | $4.04B | Mar 21, 2025 |
| FY2023 | Jan 28, 2023 | $4.08B | Mar 22, 2024 |
| FY2022 | Jan 29, 2022 | $3.62B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $2.55B | Mar 25, 2022 |
| FY2019 | Feb 1, 2020 | $6.38B | Mar 30, 2020 |
| FY2019 | Feb 2, 2019 | $6.44B | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $5.75B | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | $4.32B | Apr 4, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $828.00M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $828.00M | Mar 27, 2026 |
| FY2024 | Feb 3, 2024 | $828.00M | Mar 21, 2025 |
| FY2023 | Jan 28, 2023 | $828.00M | Mar 22, 2024 |
| FY2022 | Jan 29, 2022 | $828.00M | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $828.00M | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $3.91B | Mar 29, 2021 |
| FY2019 | Feb 2, 2019 | $3.91B | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $3.90B | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | $3.90B | Apr 4, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $6.94B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $6.50B | Mar 27, 2026 |
| FY2024 | Feb 3, 2024 | $6.09B | Mar 21, 2025 |
| FY2023 | Jan 28, 2023 | $6.27B | Mar 22, 2024 |
| FY2022 | Jan 29, 2022 | $5.27B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $3.93B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $7.99B | Mar 29, 2021 |
| FY2019 | Feb 2, 2019 | $8.05B | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $7.25B | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | $6.09B | Apr 4, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.25B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $1.31B | Mar 27, 2026 |
| FY2024 | Feb 3, 2024 | $1.03B | Mar 21, 2025 |
| FY2023 | Jan 28, 2023 | $862.00M | Mar 22, 2024 |
| FY2022 | Jan 29, 2022 | $1.71B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $1.68B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $685.00M | Mar 29, 2021 |
| FY2019 | Feb 2, 2019 | $1.16B | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $1.46B | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | $1.30B | Apr 4, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Feb 3, 2024 | $3.00B | Mar 22, 2024 |
| FY2023 | Jan 28, 2023 | $3.00B | Mar 22, 2024 |
| FY2022 | Jan 29, 2022 | $3.30B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $4.32B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $3.70B | Mar 29, 2021 |
| FY2019 | Feb 2, 2019 | $4.41B | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $5.75B | Apr 3, 2019 |
| FY2016 | Jan 28, 2017 | $6.44B | Mar 29, 2017 |
| FY2016 | Jan 30, 2016 | $6.76B | Mar 29, 2017 |
| FY2015 | Jan 31, 2015 | $8.22B | Mar 30, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 2 | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | 2 | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | 4 | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | 4 | Mar 22, 2024 |
| FY2020 | Jan 30, 2021 | 0 | Mar 29, 2021 |
| FY2020 | Oct 31, 2020 | 0 | Mar 29, 2021 |
| FY2020 | Aug 1, 2020 | (1) | Mar 29, 2021 |
| FY2020 | May 2, 2020 | (11) | Mar 29, 2021 |
| FY2020 | Feb 1, 2020 | 1 | Mar 29, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 2 | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | 2 | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | 4 | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | 4 | Mar 22, 2024 |
| FY2020 | Jan 30, 2021 | 0 | Mar 29, 2021 |
| FY2020 | Oct 31, 2020 | 0 | Mar 29, 2021 |
| FY2020 | Aug 1, 2020 | (1) | Mar 29, 2021 |
| FY2020 | May 2, 2020 | (11) | Mar 29, 2021 |
| FY2020 | Feb 1, 2020 | 1 | Mar 29, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 263.00M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | 277.69M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | 274.23M | Mar 27, 2026 |
| FY2025 | Jan 28, 2023 | 271.35M | Mar 27, 2026 |
| FY2024 | Jan 29, 2022 | 292.36M | Mar 21, 2025 |
| FY2023 | Jan 30, 2021 | 310.50M | Mar 22, 2024 |
| FY2022 | Feb 1, 2020 | 309.03M | Mar 24, 2023 |
| FY2021 | Feb 2, 2019 | 307.52M | Mar 25, 2022 |
| FY2020 | Feb 3, 2018 | 304.77M | Mar 29, 2021 |
| FY2019 | Jan 28, 2017 | 304.06M | Mar 30, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $197.00M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $192.00M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $181.00M | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $173.00M | Mar 21, 2025 |
| FY2023 | Jan 29, 2022 | $90.00M | Mar 22, 2024 |
| FY2022 | Jan 30, 2021 | $117.00M | Mar 24, 2023 |
| FY2021 | Feb 1, 2020 | $466.00M | Mar 25, 2022 |
| FY2020 | Feb 2, 2019 | $463.00M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $461.00M | Mar 30, 2020 |
| FY2018 | Jan 28, 2017 | $459.00M | Apr 3, 2019 |